Erratum: A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18-40 year old subjects with diagnosed atopic dermatitis (PLoS ONE (2015) 10:11 (e0142802))

Richard N. Greenberg; Maria Yadira Hurley; Dinh V. Dinh; Serena Mraz; Javier Gomez Vera; Dorothea Von Bredow; Alfred Von Krempelhuber; Siegfried Roesch; Garth Virgin; Nathaly Arndtz-Wiedemann; Thomas Peter Meyer; Darja Schmidt; Richard Nichols; Philip Young; Paul Chaplin

doi:10.1371/journal.pone.0142802

Erratum: A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18-40 year old subjects with diagnosed atopic dermatitis (PLoS ONE (2015) 10:11 (e0142802))

Richard N. Greenberg
, Maria Yadira Hurley
, Dinh V. Dinh
, Serena Mraz
, Javier Gomez Vera
, Dorothea Von Bredow
, Alfred Von Krempelhuber
, Siegfried Roesch
, Garth Virgin
, Nathaly Arndtz-Wiedemann
, Thomas Peter Meyer
, Darja Schmidt
, Richard Nichols
, Philip Young
, Paul Chaplin

Internal Medicine

Producción científica: Comment/debate

6 Citas (Scopus)

Idioma original	English
Número de artículo	e0142802
Publicación	PLoS ONE
Volumen	10
N.º	11
DOI	https://doi.org/10.1371/journal.pone.0142802
Estado	Published - nov 10 2015

ASJC Scopus subject areas

General

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1371/journal.pone.0142802

Otros archivos y enlaces

Huella

Profundice en los temas de investigación de 'Erratum: A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18-40 year old subjects with diagnosed atopic dermatitis (PLoS ONE (2015) 10:11 (e0142802))'. En conjunto forman una huella única.

Citar esto

Greenberg, R. N., Hurley, M. Y., Dinh, D. V., Mraz, S., Vera, J. G., Von Bredow, D., Von Krempelhuber, A., Roesch, S., Virgin, G., Arndtz-Wiedemann, N., Meyer, T. P., Schmidt, D., Nichols, R., Young, P., & Chaplin, P. (2015). Erratum: A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18-40 year old subjects with diagnosed atopic dermatitis (PLoS ONE (2015) 10:11 (e0142802)). PLoS ONE, 10(11), Artículo e0142802. https://doi.org/10.1371/journal.pone.0142802

@article{0cda84bd76de411f96e2ffaa3a3c20f2,

title = "Erratum: A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18-40 year old subjects with diagnosed atopic dermatitis (PLoS ONE (2015) 10:11 (e0142802))",

author = "Greenberg, \{Richard N.\} and Hurley, \{Maria Yadira\} and Dinh, \{Dinh V.\} and Serena Mraz and Vera, \{Javier Gomez\} and \{Von Bredow\}, Dorothea and \{Von Krempelhuber\}, Alfred and Siegfried Roesch and Garth Virgin and Nathaly Arndtz-Wiedemann and Meyer, \{Thomas Peter\} and Darja Schmidt and Richard Nichols and Philip Young and Paul Chaplin",

year = "2015",

month = nov,

day = "10",

doi = "10.1371/journal.pone.0142802",

language = "English",

volume = "10",

number = "11",

}

Greenberg, RN, Hurley, MY, Dinh, DV, Mraz, S, Vera, JG, Von Bredow, D, Von Krempelhuber, A, Roesch, S, Virgin, G, Arndtz-Wiedemann, N, Meyer, TP, Schmidt, D, Nichols, R, Young, P & Chaplin, P 2015, 'Erratum: A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18-40 year old subjects with diagnosed atopic dermatitis (PLoS ONE (2015) 10:11 (e0142802))', PLoS ONE, vol. 10, n.º 11, e0142802. https://doi.org/10.1371/journal.pone.0142802

Erratum: A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18-40 year old subjects with diagnosed atopic dermatitis (PLoS ONE (2015) 10:11 (e0142802)). / Greenberg, Richard N.; Hurley, Maria Yadira; Dinh, Dinh V. et al.
En: PLoS ONE, Vol. 10, N.º 11, e0142802, 10.11.2015.

Producción científica: Comment/debate

TY - JOUR

T1 - Erratum

T2 - A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18-40 year old subjects with diagnosed atopic dermatitis (PLoS ONE (2015) 10:11 (e0142802))

AU - Greenberg, Richard N.

AU - Hurley, Maria Yadira

AU - Dinh, Dinh V.

AU - Mraz, Serena

AU - Vera, Javier Gomez

AU - Von Bredow, Dorothea

AU - Von Krempelhuber, Alfred

AU - Roesch, Siegfried

AU - Virgin, Garth

AU - Arndtz-Wiedemann, Nathaly

AU - Meyer, Thomas Peter

AU - Schmidt, Darja

AU - Nichols, Richard

AU - Young, Philip

AU - Chaplin, Paul

PY - 2015/11/10

Y1 - 2015/11/10

UR - https://www.scopus.com/pages/publications/84953213735

UR - https://www.scopus.com/pages/publications/84953213735#tab=citedBy

U2 - 10.1371/journal.pone.0142802

DO - 10.1371/journal.pone.0142802

M3 - Comment/debate

AN - SCOPUS:84953213735

SN - 1932-6203

VL - 10

JO - PLoS ONE

JF - PLoS ONE

IS - 11

M1 - e0142802

ER -

Greenberg RN, Hurley MY, Dinh DV, Mraz S, Vera JG, Von Bredow D et al. Erratum: A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18-40 year old subjects with diagnosed atopic dermatitis (PLoS ONE (2015) 10:11 (e0142802)). PLoS ONE. 2015 nov 10;10(11):e0142802. doi: 10.1371/journal.pone.0142802